Terumo is Rising to the Challenges to Innovate in Three Business Areas
Terumo contributes to society through healthcare by doing business through three companies.
We provide optimal products and services to medical settings the world over. In pursuing higher quality in medicine, we introduce improvements for greater safety and ease of use, conduct training to promote proper use of devices, and propose systems for comprehensively meeting the needs of medical settings.
Net Sales by Company/
Percentage of Sales
- ※1 Terumo Interventional Systems: cardiac and endovascular interventional therapies
- ※2 Cardiovascular Systems: cardiac and vascular surgery
- ※3 Drug and Device: devices developed by combining drug and medical device technologies
- ※4 Diabetes Management
Cardiac & Vascular Company
Realizing minimally invasive treatments through endovascular interventions for various parts of the body and in cardiovascular surgery
The Cardiac and Vascular Company specializes in two primary therapeutic areas—endovascular intervention and cardiovascular surgery. Endovascular intervention uses catheters, thin tubular devices inserted into the patient’s blood vessel, to perform diagnostic or therapeutic procedures. These procedures are performed within or via blood vessels in various parts of the body. Terumo focuses on coronary, peripheral, and neurovascular interventions, and interventional oncology in the form of chemo-embolization for liver cancer.
In the area of cardiovascular surgery, we develop cardiopulmonary bypass systems, artificial vascular grafts, and other products. Our goal in all of these areas is to lower physical burdens on patients and achieve better therapeutic effectiveness.
General Hospital Company
The General Hospital Company contributes to higher quality in medicine by providing medical devices and pharmaceuticals in systems designed to improve safety and ease of use
Medical treatment settings have diversified and now extend from hospitals to patients’ homes. Medical devices and pharmaceuticals, therefore, must incorporate performance and design considerations tailored to the settings where they will be used.
The General Hospital Company, in order to provide coordinated systems for medical settings and enable their proper and efficient use, takes steps such as combining medical devices and pharmaceuticals, and utilizing IT solutions to harness the power of data. By adding new value to these vital systems, the company contributes to safer medical settings and more efficient workflow for medical professionals.
Blood Management Company (Terumo BCT)
The Blood Management Company drives customer value and enhances patient outcomes through blood component, therapeutic apheresis, and cellular technologies
As a global leader in blood component, therapeutic apheresis, and cellular technologies, the Blood Management Company (Terumo BCT) is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.